Xeris Biopharma Holdings Inc (XERS)
R&D Expenses
$34.81M
TTM · Period ending: · USD
XERS R&D Expenses
Latest reported$34.81Mperiod ending
Latest reported$34.81Mperiod ending
XERS TTM R&D Expenses ($20.17M → $34.81M)
TTM R&D Expenses
High-resolution chart · PNG
XERS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 34,809,000 | |
| 32,195,000 | |
| 31,165,000 | |
| 29,383,000 | |
| 27,788,000 | |
| 25,492,000 | |
| 25,560,000 | |
| 25,850,000 | |
| 24,996,000 | |
| 25,324,000 | |
| 22,341,000 | |
| 20,914,000 | |
| 21,923,000 | |
| 19,554,000 | |
| 20,966,000 | |
| 26,093,000 | |
| 25,713,000 | |
| 27,378,000 | |
| 25,160,000 | |
| 20,188,000 | |
| 18,401,000 | |
| 18,307,000 | |
| 20,921,000 | |
| 28,231,000 | |
| 39,873,000 | |
| 53,917,000 | |
| 60,438,000 | |
| 60,408,000 | |
| 55,765,000 | |
| 45,109,000 | |
| 40,654,000 | |
| 34,842,000 | |
| 29,692,000 | |
| 25,216,000 | |
| 20,166,000 |